Neoantigen-based Personalized DNA Vaccine

· Washington University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Neoantigen-based Personalized DNA Vaccine, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma [Phase 1]